Clinical Trials Browser

Sinonasal Squamous Cell Carcinoma

Oropharyngeal Neoplasms

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

Pathologic Complete Response, Rectal Neoplasms

Infiltrating Bladder Urothelial Carcinoma

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

Carcinoma, Non-Small-Cell Lung

Pancreatic Neoplasms

Hypopharyngeal Neoplasms

Carcinoma, Non-Small-Cell Lung

Oropharyngeal Neoplasms

Carcinoma, Oropharyngeal Neoplasms

Glioblastoma

Rectal Malignant Neoplasms

Chemoradiotherapy

Myelosuppression

Nasopharyngeal Carcinoma

Esophageal Neoplasms

Esophageal Neoplasms

Locally Advanced Hypopharyngeal Carcinoma

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Clinical Trials

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer

(NeoScorch HN)

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

InDuRanS

PANC

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

G-CSF After Chemo-radiation in Patients With Glioblastoma

Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT)

Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy

Trilaciclib Prevents Myelosuppression With Chemoradiotherapy

GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma

Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients

Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma

Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer

Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer